Key result
Treatment with a combination of Sophora flavescens alkaloids and Panax quinquefolium saponins significantly reduced myocardial inflammation at 21 days and delayed myocardial fibrosis at 60 days in mice with experimental autoimmune myocarditis.
Why the study?
Because Panax quinquefolium saponins alleviate cardiac fibrosis, the potential effects of their combination with Sophora flavescens alkaloids (KX) on different stages of autoimmune myocarditis were investigated.
Does the combination of Sophora flavescens alkaloids and Panax quinquefolium saponins (KX) reduce inflammation and fibrosis in a mouse model of experimental autoimmune myocarditis?
Does the combination of Sophora flavescens alkaloids and Panax quinquefolium saponins (KX) reduce inflammation and fibrosis in a mouse model of experimental autoimmune myocarditis?
The combination of Sophora flavescens alkaloids and Panax quinquefolium saponins attenuates inflammation and fibrosis in experimental autoimmune myocarditis by modulating the NF-κB and TGF-β1 pathways.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for KX in autoimmune myocarditis models; leaves open clinical translation and human trials.
saponins (XiYangShen) has been shown to alleviate cardiac fibrosis. Therefore, the potential effects of their combination (KX) on different stages of autoimmune myocarditis were investigated in the present study. Mice were randomly divided into the following four groups: Control; experimental autoimmune myocarditis (EAM); KX-High (275 mg/kg); and KX-Low (138 mg/kg). A 21-day and a 60-day EAM model was established through multi-site subcutaneous injections of cardiac myosin mixed with complete Freund's adjuvant on days 0, 7, 21 and 42. Mice in the High and Low KX groups were treated by gavage (10 ml/kg) daily from day 0 (1 day before treatment) until sacrifice (day 21 or 60). Mice in the control and EAM groups received an equivalent volume of distilled water. The levels of lactate dehydrogenase (LDH), creatine kinase-myocardial band (CK-MB), cardiac troponin I (cTn-I), IL-1β, IL-6, TNF-α, TGF-β1, collagen type I (Col Ⅰ) and collagen type III (Col Ⅲ) were measured by ELISA in the mouse myocardial tissues or serum. Myocardial tissue structure and extent of fibrosis were visualized using H&E and Masson's staining. Western blotting and immunohistochemistry were used to measure the expression levels NF-κB and TGF-β1 pathway proteins in the myocardial tissues. The degree of inflammation in the 21-day EAM model was found to be significantly higher compared with that in the 60-day EAM model. KX significantly reduced the inflammatory response at 21 days by decreasing the expression levels of CK-MB, LDH, cTn-I, IL-1β, IL-6, TNF-α and TGF-β-activated kinase 1-binding protein 1/NF-κB pathway proteins. Myocardial fibrosis in the 60-day EAM model was also significantly worse compared with that in the 21-day EAM model. However, fibrosis was significantly delayed by treatment with KX. In addition, KX significantly decreased the expression levels of TGF-β1, Smad2, Smad4, Col I and Col III. Therefore, these data suggest that KX is beneficial for treating myocarditis by targeting multiple pathways.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) studied Experimental autoimmune myocarditis (n=96). Combination of Sophora flavescens alkaloids and Panax quinquefolium saponins (KX) vs. Distilled water (EAM control) was evaluated on Myocardial inflammation and fibrosis markers (CK-MB, LDH, cTn-I, IL-1β, IL-6, TNF-α, TGF-β1, Col I, Col III) (p=<0.05). Treatment with a combination of Sophora flavescens alkaloids and Panax quinquefolium saponins significantly reduced myocardial inflammation at 21 days and delayed myocardial fibrosis at 60 days in mice with experimental autoimmune myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: